CD274 and neoplasm: On the one hand, the inhibitors of VEGFR can not only facilitate the restructuring of tumor blood vessels, promoting vascular normalization and consequently enhancing the efficacy and resistance to chemotherapy and anti-PD-1/PD-L1 treatment [29], but also exhibit the capability to suppress the immune-inhibitory myeloid cell recruitment induced by VEGF-A.